COVID-19 impairs the insulin/IGF signaling pathway

Scientists evaluate the impact of SARS-CoV-2 on the insulin/IGF signaling pathway.
Scientists evaluate the impact of SARS-CoV-2 on the insulin/IGF signaling pathway.